Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Walking buddy program aims to boost survival in prostate cancer patients

NCT ID NCT05739565

Disease control Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program that helps prostate cancer patients become more physically active. It combines a personalized exercise plan, coaching from a fellow patient who is already active, and support from a doctor. The goal is to see if this approach helps men stay active long-term, which can lower the risk of cancer returning and improve overall health. About 850 men who are currently inactive will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 850 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients: * Age ≥ 18 years * Diagnosed with prostate cancer for at least 1 year * PA practice \< 150 minutes per week (considered inactive according to WHO) * Affiliated or entitled to a social security scheme * Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: For patients: * Undergoing treatment (except hormone therapy) * Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies * Deprived of liberty or under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    25 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Activité Physique Adaptée - CDOS Ardèche

    NOT_YET_RECRUITING

    Privas, France

  • Activité Physique Adaptée - CDOS Drôme

    NOT_YET_RECRUITING

    Valence, France

  • Activité Physique Adaptée - CDOS Isère

    NOT_YET_RECRUITING

    Grenoble, France

  • Activité Physique Adaptée - CDOS Savoie

    NOT_YET_RECRUITING

    Chambéry, France

  • Activité Physique Adaptée - DAHLIR 43

    NOT_YET_RECRUITING

    Le Puy-en-Velay, France

  • Activité Physique Adaptée - DAHLIR 63

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

  • Activité Physique Adaptée - DAHLIR 69

    NOT_YET_RECRUITING

    Lyon, France

  • Activité Physique Adaptée - DAPAP 42

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • CH Chambéry

    NOT_YET_RECRUITING

    Chambéry, France

  • CH Le Puy en Velay

    NOT_YET_RECRUITING

    Le Puy-en-Velay, France

  • CH Roanne

    NOT_YET_RECRUITING

    Roanne, France

  • CHU Clermont-Ferrand - ONCOLOGIE

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

  • CHU Clermont-Ferrand - Urologie

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

  • CHU Grenoble - Urologie

    NOT_YET_RECRUITING

    Grenoble, France

  • CHU Saint-Etienne - Oncologie

    RECRUITING

    Saint-Etienne, France

  • CHU Saint-Etienne - Radiothérapie

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • CLB - Oncologie

    NOT_YET_RECRUITING

    Lyon, France

  • CLB - Radiothérapie

    NOT_YET_RECRUITING

    Lyon, France

  • Clinique du parc

    NOT_YET_RECRUITING

    Saint-Priest-en-Jarez, 42270, France

  • HCL - CH Lyon Sud

    NOT_YET_RECRUITING

    Lyon, France

  • HCL - Hôpital Croix Rousse

    NOT_YET_RECRUITING

    Lyon, 69004, France

  • HCL - Hôpital Edouard Herriot

    NOT_YET_RECRUITING

    Lyon, 69000, France

  • Hôpital Privé de la Loire

    RECRUITING

    Saint-Etienne, France

  • Hôpitaux Drôme Nord - Valence

    NOT_YET_RECRUITING

    Valence, France

  • Radiologie Drôme-Ardèche - Valence

    NOT_YET_RECRUITING

    Valence, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.